Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Charles Fruchart

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
Clinical Science (London, England : 1979)|August 24, 2002
HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cellsAbdelmejid Kandoussi, François Martin, Marc Hazzan, et al.
The Journal of Biological Chemistry|October 7, 2005
Extracellular human thioredoxin-1 inhibits lipopolysaccharide-induced interleukin-1beta expression in human monocyte-derived macrophagesLudivine Billiet, Christophe Furman, Guilhem Larigauderie, et al.
The Journal of Nutrition|August 7, 2002
The plasma and lipoprotein triglyceride postprandial response to a carbohydrate tolerance test differs in lean and massively obese normolipidemic womenJean Dallongeville, Amandine Harbis, Pascal Lebel, et al.
The Journal of Biological Chemistry|June 18, 2003
Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzymeOlivier Barbier, Daniel Duran-Sandoval, Inés Pineda-Torra, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 5, 2005
PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemiaNathalie Hennuyer, Anne Tailleux, Gérard Torpier, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 21, 2006
Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase geneOscar Pérez-Méndez, Nathalie Duhal, Brigitte Lacroix, et al.
Diabetologia|May 3, 2005
Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetesAnne Hiukka, Jamila Fruchart-Najib, Eeva Leinonen, et al.
Diabetes Care|May 9, 2007
The increase of apolipoprotein A-V during postprandial lipemia parallels the response of triglyceride-rich lipoproteins in type 2 diabetes: no relationship between apoA-V and postheparin plasma lipolytic activityJuhani Kahri, Jamila Fruchart-Najib, Niina Matikainen, et al.
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
DNA binding-independent induction of IkappaBalpha gene transcription by PPARalphaPhilippe Delerive, Karolien De Bosscher, Wim Vanden Berghe, et al.
The Journal of Pharmacy and Pharmacology|November 27, 2004
Natural phenylpropanoids inhibit lipoprotein-induced endothelin-1 secretion by endothelial cellsFrançoise Martin-Nizard, Sevser Sahpaz, Abdelmejid Kandoussi, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Clinical Science (London, England : 1979)|August 24, 2002
HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cellsAbdelmejid Kandoussi, François Martin, Marc Hazzan, et al.
The Journal of Biological Chemistry|October 7, 2005
Extracellular human thioredoxin-1 inhibits lipopolysaccharide-induced interleukin-1beta expression in human monocyte-derived macrophagesLudivine Billiet, Christophe Furman, Guilhem Larigauderie, et al.
The Journal of Nutrition|August 7, 2002
The plasma and lipoprotein triglyceride postprandial response to a carbohydrate tolerance test differs in lean and massively obese normolipidemic womenJean Dallongeville, Amandine Harbis, Pascal Lebel, et al.
The Journal of Biological Chemistry|June 18, 2003
Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzymeOlivier Barbier, Daniel Duran-Sandoval, Inés Pineda-Torra, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 5, 2005
PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemiaNathalie Hennuyer, Anne Tailleux, Gérard Torpier, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 21, 2006
Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase geneOscar Pérez-Méndez, Nathalie Duhal, Brigitte Lacroix, et al.
Diabetologia|May 3, 2005
Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetesAnne Hiukka, Jamila Fruchart-Najib, Eeva Leinonen, et al.
Diabetes Care|May 9, 2007
The increase of apolipoprotein A-V during postprandial lipemia parallels the response of triglyceride-rich lipoproteins in type 2 diabetes: no relationship between apoA-V and postheparin plasma lipolytic activityJuhani Kahri, Jamila Fruchart-Najib, Niina Matikainen, et al.
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
DNA binding-independent induction of IkappaBalpha gene transcription by PPARalphaPhilippe Delerive, Karolien De Bosscher, Wim Vanden Berghe, et al.
The Journal of Pharmacy and Pharmacology|November 27, 2004
Natural phenylpropanoids inhibit lipoprotein-induced endothelin-1 secretion by endothelial cellsFrançoise Martin-Nizard, Sevser Sahpaz, Abdelmejid Kandoussi, et al.
Pageof 17